Written by LAURAN NEERGAARD

Pfizer said Wednesday that a booster dose of its COVID-19 vaccine may offer important protection against the new omicron variant even though the initial two doses appear significantly less effective.

Pfizer and its partner BioNTech said that while two doses may not be protective enough to prevent infection, lab tests showed a booster increased by 25-fold people’s levels of virus-fighting antibodies against the omicron variant.

Blood samples taken a month after a booster showed people harbored levels of omicron-neutralizing antibodies that were similar to amounts proven protective against earlier variants after two doses.

Scientists don’t yet know how big a threat the omicron variant really is. Currently the extra-contagious delta variant is responsible for most of the COVID-19 cases in the U.S. and other countries.

But the omicron variant, discovered late last month, carries an unusually large number of mutations and scientists are racing to learn how easily it spreads, whether it causes illness that is more serious or milder than other coronavirus types — and how much it might evade the protection of prior vaccinations.

Pfizer’s findings, announced in a press release, are preliminary and haven’t yet undergone scientific review. But they’re the first from a vaccine maker examining whether the booster doses that health authorities are urging people to get may indeed make an important difference.

Scientists have speculated that the high jump in antibodies that comes with a third dose of COVID-19 vaccines might be enough to counter any decrease in effectiveness.

Pfizer and BioNTech already are working to create an omicron-specific vaccine in case it’s needed.

Antibody levels predict how well a vaccine may prevent infection with the coronavirus but they are just one layer of the immune system’s defenses. Pfizer said two doses of the vaccine should still protect against severe disease, because the mutations in omicron don’t appear to hamper one of those other defenses, T cells that fight the virus after infection sets in.

“Although two doses of the vaccine may still offer protection against severe disease caused by the Omicron strain, it’s clear from these preliminary data that protection is maximized with a third dose of our vaccine,” Pfizer CEO Albert Bourla said in a statement.

Pfizer’s announcement had an immediate impact on U.S. markets. Futures that had pointed to a lower open reversed course in seconds and swung solidly to the positive with the Dow jumping almost 200 points.

 

Photo via AP Photo/Steven Senne.

 

Related Stories
‹
EU Moves Toward Stricter Export Controls for COVID Vaccines
Written by RAF CASERT The European Union is moving toward stricter export controls to ensure that there are more COVID-19 shot supplies for the bloc which should boost its flagging vaccine drive at a time of another surge of the coronavirus pandemic on the continent. The EU’s executive body said Wednesday on the eve of a […]
Astrazeneca: U.S. Data Shows Vaccine Effective for All Ages
Written by MARIA CHENG and LAURAN NEERGAARD AstraZeneca’s COVID-19 vaccine provided strong protection against sickness and eliminated hospitalizations and deaths from the disease across all age groups in a late-stage study in the United States, the company announced Monday. AstraZeneca said its experts did not identify any safety concerns related to the vaccine, including finding no […]
A Rapid COVID-19 Vaccine Rollout Backfired in Some U.S. States
Written by CARLA K. JOHNSON and NICKY FORSTER Despite the clamor to speed up the U.S. vaccination drive against COVID-19 and get the country back to normal, the first three months of the rollout suggest faster is not necessarily better. A surprising new analysis found that states such as South Carolina and Florida that raced ahead […]
Biden Admin To Administer 3,000 Daily Vaccines in Greensboro
The White House announced Friday morning that it will include North Carolina in its federal pilot program of community vaccination centers. Starting March 10, a Greensboro site will receive about 3,000 vaccines per day. The timing aligns with Gov. Roy Cooper’s expansion of vaccine eligibility to frontline essential workers. Teachers, child care workers and school […]
AP-NORC Poll: A Third of U.S. Adults Skeptical of COVID Shots
About 1 in 3 Americans say they definitely or probably won’t get the COVID-19 vaccine, according to a new poll that some experts say is discouraging news if the U.S. hopes to achieve herd immunity and vanquish the outbreak. The poll from The Associated Press-NORC Center for Public Affairs Research found that while 67% of […]
North Carolina Prisons Offer Incentives for Offenders to Get Vaccine
Most North Carolina prisoners can get five days knocked off their sentences if they receive COVID-19 vaccinations, state corrections officials said on Friday. A package of incentives, which also include extra visitations and a free 10-minute phone call, were unveiled a few weeks after prison leaders said they were considering ways to motivate prisoners to […]
Cooper Visits Clinic Pushing To Overcome Vaccine Hesitancy
North Carolina Gov. Roy Cooper on Thursday visited Piedmont Health SeniorCare in Pittsboro to gather ideas about how to help overcome the reluctance of some to get the COVID-19 vaccine. The federally qualified health center that administers doses with an emphasis on serving racial and ethnic minority groups said it first worked to overcome hesitancy […]
North Carolina Health Officials Say 1,280 COVID Doses Wasted
North Carolina’s Department of Health and Human Services said on Friday that the state has seen 1,280 of its coronavirus vaccine doses get discarded. “Only 0.1% (or 1,280) of the 1.1 million doses which have entered the state thus far have become unusable for any reason and we have not received reports of significant batches […]
More Than 4,200 Register for Coronavirus Vaccinations in Orange County
More than 4,200 residents have applied to receive the COVID-19 vaccine through Phase 1B of distribution, the Orange County Health Department announced on Friday. This week, North Carolina moved into Phase 1B of distribution — meaning all residents age 75 and older can apply to receive the coronavirus vaccine. Orange County confirmed that appointment slots […]
Pfizer Says COVID Booster Offers Protection Against Omicron
Written by LAURAN NEERGAARD Pfizer said Wednesday that a booster dose of its COVID-19 vaccine may offer important protection against the new omicron variant even though the initial two doses appear significantly less effective. Pfizer and its partner BioNTech said that while two doses may not be protective enough to prevent infection, lab tests showed a booster […]
›